MarketCapTrends
RCKT

Rocket Pharmaceuticals Inc. (RCKT)

NASDAQ · Healthcare

Rocket Pharmaceuticals Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Rocket Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 53.2M, a 17.43% decrease year-over-year.
  • Rocket Pharmaceuticals Inc. total liabilities for 2025 were 53.2M, a 17.43% decrease from 2024.
  • Rocket Pharmaceuticals Inc. total liabilities for 2024 were 64.5M, a 12.61% decrease from 2023.
  • Rocket Pharmaceuticals Inc. total liabilities for 2023 were 73.8M, a 18.75% increase from 2022.
  • Rocket Pharmaceuticals Inc. total liabilities for 2022 were 62.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Rocket Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $)
2025$53
2024$64
2023$74
2022$62
2021$42
2020$87
2019$65
2018$57
2017$5
2016$56
Rocket Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$53
2024-12-31$64
2023-12-31$74
2022-12-31$62
2021-12-31$42
2020-12-31$87
2019-12-31$65
2018-12-31$57
2017-12-31$5
2016-12-31$56

Rocket Pharmaceuticals Inc. Total Liabilities — FAQ

Rocket Pharmaceuticals Inc. (RCKT) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RCKT's total liabilities history?

The chart and table above show Rocket Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.